Daily Archives: 8 August 2024

Charting the Heart to Avert Damage from Heart Attacks

Researchers at the Victor Chang Cardiac Research Institute in Australia have developed an unprecedented integrated map of heart cells, shedding light on the processes behind cardiac fibrosis—a leading cause of heart failure. This innovative map lays the foundation for the development of precision drugs designed to prevent the scarring damage that occurs after a heart attack. When a heart attack strikes, it causes damage to the heart’s muscles, resulting in scar tissue that lacks the elasticity and contractility of healthy muscle. This permanent damage diminishes the heart’s ability to pump blood efficiently, often leading to heart failure.

Professor Richard Harvey led the study in collaboration with Dr Ralph Patrick and Dr Vaibhao Janbandhu from the institute. Professor Harvey emphasized that the research marks a significant advance in understanding cardiac fibrosis, which is prevalent in various heart diseases, including those exacerbated by high blood pressure. He pointed out the considerable investments in finding new drugs to control cardiac fibrosis, which have been mainly unsuccessful, underscoring the urgent need for innovative treatments capable of halting or even reversing this condition.

Professor Harvey explained that while fibrosis is a natural healing process of the body, in the heart, it can become excessive due to unresolved disease triggers, leading to scarring that severely impairs heart function and becomes a primary cause of heart failure. The team employed state-of-the-art technology to analyze gene expression in single cells. This allowed them to delineate the progression of cellular states involved in cardiac fibrosis and how these evolve. Their methodology involved analyzing RNA signatures from 100,000 individual cells, focusing on those involved in fibrosis, and integrating this data with findings from various pioneering studies on different heart conditions.

This comprehensive approach enabled the creation of an intricate cellular map of a mouse model heart, pinpointing cells and pathways that play roles in fibrosis. The researchers identified various cellular states, including resting, activated, inflammatory, and progenitor cells, as well as dividing cells and specialized cells known as myofibroblasts and matrifibrocytes. They discovered that myofibroblasts, which are absent in healthy hearts but are believed to drive scarring, begin to form three days after a heart attack, peaking on the fifth day and then transitioning into matrifibrocytes, which potentially hinder the scar’s resolution.

The findings, published in Science Advances, also explored heart disease models such as heart failure induced by conditions like hypertension due to aortic stenosis. Dr Janbandhu noted a surprising similarity in the progression of fibrosis across different types of heart diseases, with myofibroblasts appearing early on during hypertension and then transitioning into matrifibrocytes, similar to their behaviour after a heart attack. This discovery opens the doors to future therapies that could target specific cell types or processes across various heart conditions, offering hope for preventing permanent damage to healthy cells and improving patient outcomes.

The study, which utilized data from both mouse models and human patients, indicates that heart failure in humans can evolve over decades. This underscores the importance of regular monitoring and effective management of blood pressure, a major risk factor for severe heart conditions. Dr Janbandhu’s emphasis on the treatable nature of persistent high blood pressure and the potential to prevent devastating consequences through proactive management should inspire a sense of responsibility and proactivity in the audience.

More information: Ralph Patrick et al, Integration mapping of cardiac fibroblast single-cell transcriptomes elucidates cellular principles of fibrosis in diverse pathologies, Science Advances. DOI: 10.1126/sciadv.adk8501

Journal information: Science Advances Provided by Victor Chang Cardiac Research Institute

Investigating the Strategies for Addressing Market-Driven Epidemics

Leave a Reply

A definition for market-driven epidemics (MDEs) could significantly alleviate the obstacles faced in timely and effective prevention and mitigation, suggests a study recently released in the open-access journal PLOS Global Public Health. The study’s authors, including Jonathan Quick from the Duke University School of Medicine in the U.S., highlight how certain consumer products contribute to global risk factors for premature deaths across all age groups, costing the global economy trillions of dollars. Despite concerted efforts, reducing mortality related to these products has proven challenging, slow, and frequently unsuccessful. Quick and his team have established a case definition for MDEs to tackle this issue, which occurs when companies intensively market harmful products, deny the associated risks, and obstruct mitigation measures. The paper outlines the application of this definition through the analysis of three MDE products: cigarettes, sugar, and prescription opioids. The researchers map out five phases of MDEs based on the history of these products: market expansion, evidence of harm, corporate resistance, mitigation, and market adaptation.

The study notes a significant decline in the consumption of these products in the U.S. from their consumption peaks to the latest data available: cigarette sales dropped by 82%, sugar consumption decreased by 15%, and prescriptions for prescription opioids went down by 62%. The turning point in consumption for each product was marked by convincing evidence of harm, professional concern, and significant public health advocacy or mobilization that countered corporate marketing and resistance efforts. The interval between initial suspicion of damage and consumption tipping point varied from one to five decades, mainly due to the time needed to accumulate adequate evidence of harm. The authors also discuss how market adaptation to the decreased consumption of these products has had both adverse effects, such as the geographical relocation of marketing efforts, and positive impacts, such as consumers moving away from sugar-sweetened beverages.

The authors argue that this is the inaugural comparative analysis of successful efforts to alter the consumption patterns of millions, potentially reducing the adverse health impacts associated with these products. The MDE epidemiological framework proposed by Quick and his colleagues aims to shorten the latent time between the described phases, offering the global health community a novel approach to confronting existing and emerging harmful products and their impacts on health, society, and the economy.

The analysis underscores that while each MDE is unique in terms of the specific product and circumstances, the underlying epidemiology of consumption and health impacts and the milestones of the epidemic should inform public health leaders in combating current MDEs and more rapidly identifying potential future ones. The patterns observed across various MDEs suggest that public health officials, researchers, and civil society can employ these mitigation strategies to save lives and mitigate the effects of ongoing and emerging MDEs.

In their conclusion, the authors emphasize: “The consumption of cigarettes and other harmful products results in millions of deaths and costs the world trillions of dollars annually. Our analysis of U.S. efforts against three such market-driven epidemics shows that lives can be saved through earlier and more definitive actions by public health authorities, researchers, and through public engagement,” asserting that “the consumption patterns of cigarettes and similar products often mimic those of infectious disease epidemics, causing widespread damage before an effective public health intervention is implemented. By recognizing these market-driven epidemics sooner and responding more decisively, we can save numerous lives.”

More information: Eszter Rimányi et al, Dynamics of combatting market-driven epidemics: Insights from U.S. reduction of cigarette, sugar, and prescription opioid consumption, PLOS Global Public Health. DOI: 10.1371/journal.pgph.0003479

Journal information: PLOS Global Public Health Provided by PLOS

Combined Antioxidant Formula Enhances Cognitive Function and Memory in Elderly Mice

Leave a Reply

The persistent age-related decline in cognitive and muscular function poses a significant challenge in healthcare. With the ageing population, the financial burden of managing cognitive decline and muscle weakness is expected to escalate. Oxidative stress, characterized by cumulative damage from free radicals, is a principal factor in the health deterioration associated with ageing. Antioxidants found in certain foods can neutralize these radicals, reducing cell damage and slowing the pace of age-related decline. When diets lack antioxidants, many turn to supplements that offer similar or even more excellent protection.

A groundbreaking study led by Professor Koji Fukui from the Shibaura Institute of Technology and Dr. Fukka You from Gifu University has shown promising results. Their research, involving the administration of a blended antioxidant supplement to elderly mice, led to significant improvements in spatial cognition, short-term memory, and muscle strength. Published in the ‘Antioxidants in Health and Diseases’ special issue of the International Journal of Molecular Sciences on February 28, 2024, the findings suggest that long-term intake of these supplements could effectively combat the natural oxidation increases due to ageing.

Memory loss, often linked to debilitating diseases like Alzheimer’s, disproportionately affects older individuals. The study’s results indicate that blended antioxidant supplements could potentially prevent memory loss in humans, like the effects observed in mice. Additionally, sarcopenia—an age-related condition that results in progressive muscle strength loss—significantly impacts mobility and can lead to social isolation and increased risk of cognitive disorders. The improvement in muscle strength observed in mice suggests that antioxidant supplements could also mitigate muscle frailty and sarcopenia in humans.

Professor Fukui highlighted the severity of frailty and sarcopenia as substantial issues and potent risk factors for dementia. The potential of supplements to prevent muscle weakness marks a significant advancement, although the exact mechanisms remain unclear. The marketplace offers a variety of antioxidant supplements, and choosing the right one can be a complex decision for consumers. The positive outcomes from this study support the use of blended antioxidant supplements to prevent age-related health decline. Yet, more research is needed to confirm their effectiveness and safety in humans.

It’s also crucial to understand that different antioxidant blends may vary in their effects on the human body, and their application should ideally be based on clinical evidence. The antioxidant blend used in this study, Twendee X, has a composition similar to the commercially available supplement Oxycut®. Professor Fukui advises that while many antioxidant supplements are available, the effects are more significant when multiple types are taken simultaneously rather than individually. However, determining the appropriate types and quantities can be challenging, as consuming excessive amounts of specific vitamins is possible.

Establishing the correct regimen and selecting the right supplement can be confusing for consumers. Future research into individual differences in the effects of antioxidants can help clarify the optimal dosage and composition of these supplements. Over the long term, optimal use of antioxidant supplements could significantly reduce the health declines associated with ageing.

Professor Fukui envisions a future where multi-supplements are tailored to individual needs, eliminating the concerns about overdosing. This approach would not only ensure safety but also enhance the efficacy of supplements in combating age-related decline. As research progresses, such tailored solutions could become a cornerstone in managing health in older adults, potentially transforming the landscape of age-related healthcare.

More information: Koji Fukui et al, A Blended Vitamin Supplement Improves Spatial Cognitive and Short-Term Memory in Aged Mice, International Journal of Molecular Sciences. DOI: 10.3390/ijms25052804

Journal information: International Journal of Molecular Sciences Provided by Shibaura Institute of Technology

What Processes Does the Brain Use to Make Decisions?

Leave a Reply

Scientists have unveiled significant insights into the communication between neurons during decision-making processes and the strengthening of neural connections that reinforce choices. Conducted on mice and spearheaded by neuroscientists from Harvard Medical School, this pioneering study employed a mix of structural, functional, and behavioural analyses to delve into how neuron-to-neuron connections underpin decision-making. Published on February 21 in Nature, the findings mark a crucial step in understanding the complex neural interactions that facilitate decision-making.

The study was co-authored by Wei-Chung Allen Lee, Christopher Harvey, and Stefano Panzeri. Lee noted the importance of unravelling the brain’s organizational structure in decision-making, which needs better understood. In their experiments, mice navigating a maze had to choose directions to locate rewards, revealing that decisions to turn left or right triggered sequences of neuron activations, suppressing neurons associated with the alternative direction. This specific interaction between neuron groups is pivotal in shaping decisions by deactivating alternative pathways.

The genesis of this research was an unexpected collaboration between Lee and Harvey, forged during a fire drill. This partnership combined Lee’s expertise in connectomics, which maps neural connections, with Harvey’s background in behavioural studies using virtual reality mazes to track decision-making in mice. This interdisciplinary approach allowed them to explore the complex roles and connectivity of various neuron types involved in decision-making processes.

Their focus was the posterior parietal cortex, described by Lee as an “integrative hub” that processes multisensory information to aid decision-making. The study sought to identify simple connectivity rules that the brain might use to facilitate decisions. Harvey’s lab recorded neural activities as mice navigated a virtual reality T-shaped maze, while Lee’s lab mapped the structural connections among the same neurons using advanced microscopy techniques.

The researchers successfully differentiated between excitatory neurons, which activate other neurons, and inhibitory neurons, which suppress activity. They found that when a mouse decided to turn right, specific excitatory neurons were activated, which stimulated inhibitory neurons that reduced activity in the neurons associated with turning left and vice versa. Lee suggested that this neural circuitry could help stabilize decisions by suppressing choices, a mechanism that might be conserved across species, though further confirmation in humans is needed.

The team is eager to explore neuronal connections in other brain regions involved in decision-making. Their ongoing work aims to uncover more connectivity rules that could further elucidate the complex processes through which the brain makes decisions, hoping to build a broader understanding of neural dynamics in maritime and other types of decision-making.

More information: Aaron T. Kuan et al, Synaptic wiring motifs in posterior parietal cortex support decision-making, Nature. DOI: 10.1038/s41586-024-07088-7

Journal information: Nature Provided by Harvard Medical School